These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Potency of positive gamma-aminobutyric acid(A) modulators to substitute for a midazolam discriminative stimulus in untreated monkeys does not predict potency to attenuate a flumazenil discriminative stimulus in diazepam-treated monkeys. McMahon LR; Gerak LR; France CP J Pharmacol Exp Ther; 2001 Sep; 298(3):1227-35. PubMed ID: 11504825 [TBL] [Abstract][Full Text] [Related]
3. [A case of convulsion induced by flumazenil]. Taki H; Shinomura T; Shirakami G Masui; 1996 Oct; 45(10):1247-51. PubMed ID: 8937022 [TBL] [Abstract][Full Text] [Related]
4. Chronic flumazenil alters GABA(A) receptor subunit mRNA expression, translation product assembly and channel function in neuronal cultures. Zheng TM; Caruncho HJ; Zhu WJ; Vicini S; Ikonomovic S; Grayson DR; Costa E J Pharmacol Exp Ther; 1996 Apr; 277(1):525-33. PubMed ID: 8613963 [TBL] [Abstract][Full Text] [Related]
5. The role of transcriptional and translational mechanisms in flumazenil-induced up-regulation of recombinant GABA(A) receptors. Jazvinsćak Jembrek M; Svob Strac D; Vlainić J; Pericić D Neurosci Res; 2008 Jul; 61(3):234-41. PubMed ID: 18453026 [TBL] [Abstract][Full Text] [Related]
6. Flumazenil is a benzodiazepine receptor antagonist. Khanna N Indian J Physiol Pharmacol; 2001 Jul; 45(3):386. PubMed ID: 11881583 [No Abstract] [Full Text] [Related]
7. Antagonism of the discriminative stimulus effects of positive gamma-aminobutyric acid(A) modulators in rhesus monkeys discriminating midazolam. Lelas S; Gerak LR; France CP J Pharmacol Exp Ther; 2000 Sep; 294(3):902-8. PubMed ID: 10945839 [TBL] [Abstract][Full Text] [Related]
8. Discriminative stimulus effects of positive GABAA modulators and other anxiolytics, sedatives, and anticonvulsants in untreated and diazepam-treated monkeys. McMahon LR; France CP J Pharmacol Exp Ther; 2003 Jan; 304(1):109-20. PubMed ID: 12490581 [TBL] [Abstract][Full Text] [Related]
14. [Sedation in endoscopic diagnosis: rationale of the use of specific benzodiazepine antagonists]. Chillemi S; Milici M; De Francesco F; Buda CA; Maisano C; Minutoli N; Querci A; Lemma F G Chir; 1996; 17(6-7):349-52. PubMed ID: 9272978 [TBL] [Abstract][Full Text] [Related]
15. Timing and side effects of flumazenil for dental outpatients receiving intravenous sedation with midazolam. Misaki T; Kyoda N; Oka S; Takada K; Kunimatu T; Tajima A Anesth Prog; 1997; 44(4):127-31. PubMed ID: 9481956 [TBL] [Abstract][Full Text] [Related]
16. The effects of midazolam and flumazenil on psychomotor function. Gupta A; Lind S; Eklund A; Lennmarken C J Clin Anesth; 1997 Feb; 9(1):21-5. PubMed ID: 9051541 [TBL] [Abstract][Full Text] [Related]
17. Intravenous flumazenil following prolonged exposure to lormetazepam in humans: lack of precipitated withdrawal. Gerra G; Giucasto G; Zaimovic A; Fertonani G; Chittolini B; Avanzini P; Caccavari R; Delsignore R Int Clin Psychopharmacol; 1996 Jun; 11(2):81-8. PubMed ID: 8803645 [TBL] [Abstract][Full Text] [Related]
18. [Participation of GABA--benzodiazepine receptor complex in the anxiolytic effect of piracetam]. Moldavkin GM; Voronina TA; Neznamov GG; Maletova OK; Eliava NV Eksp Klin Farmakol; 2006; 69(3):7-9. PubMed ID: 16878489 [TBL] [Abstract][Full Text] [Related]
19. A pilot controlled study of the effects of flumazenil in posttraumatic stress disorder. Coupland NJ; Lillywhite A; Bell CE; Potokar JP; Nutt DJ Biol Psychiatry; 1997 May; 41(9):988-90. PubMed ID: 9110106 [No Abstract] [Full Text] [Related]
20. Reversal of conscious sedation by flumazenil: current status and future prospects. McCloy RF Acta Anaesthesiol Scand Suppl; 1995; 108():35-42. PubMed ID: 8693923 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]